Adverse Drug Events
The NYSPFP Initiative to Reduce Adverse Drug Events (ADE) is designed to work with hospitals to implement standardized best practices around the management of high alert medications.
To promote medication safety related to high alert medications (insulin, anticoagulants, and opioids), and reduce ADEs by 20%.
NYSPFP’s approach to achieving performance excellence is embedded in a dynamic set of guiding principles designed to foster a culture of safety and continuous quality improvement. The following operationalizes the NYSPFP Guiding Principles to innovate, engage, integrate, and hardwire best practices for the reduction of ADEs.
Hospital participants receive comparative data analyses to inform their medication safety improvement efforts. The following documents outline the NYSPFP measurement strategy which, along with educational programming, is intended to provide hospitals with meaningful data to inform and help tailor interventions to reduce ADEs.